More than 1,000 health care workers at Crystal Run voted overwhelmingly to unionize, but their employer, Optum, is trying to ...

There were 122 National Labor Relations Board representation elections run in February 2025, and ten involved units of 250 or ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

A court-appointed special master says the Justice Department hasn’t developed “any evidence” for key claims. Her ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

These changes are part of ongoing efforts to reduce total UnitedHealthcare prior authorization volume," the company said.

Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies, UnitedHealth Group, has added a new, much-anticipated pain drug to some of its commercial ...